From smart diagnosis to digital testing and data-driven medical intelligence, the Chinese health tech sector is buzzing with innovation.

In case you don't know, revenue in the country's digital health market is projected to reach $47 billion in 2022 from less than $10 billion in 2017, according to data from Statista. By 2026, it is expected to surpass $70 billion.

Despite the funding freeze for startups globally, the health tech sector in China is now being backed by American startup investment behemoth Sequoia Capital. Sequoia China's reported $9 billion investment fund which would likely focus on technology and health care startups in the country is coming at a time when tech startups in China are battling a regulatory crackdown on the tech sector, new coronavirus lockdowns, a supply-chain hurdle, and global inflation.

The investment fund is significant as China-focused venture capital and private equity firms raised only $4.3 billion in the first half of 2022, compared to $26 billion in the same period last year, according to data from Preqin.

Moving away from China, other top stories we tracked this week on The Draft include a new $968 million fund from a California-based VC giant that will invest in startups across the US, Europe, Asia, and Latin America; Amazon's search for Software Developers from Lagos who want to move to North America and Europe; and a new $91 million financing boost for a Senegalese fintech startup.

To good health and wealth,

- Juwon

Looking for career opportunities in tech?

Techloy's new career series wants to assist you with the info, insight, and resources that you need to take your career in tech to the next level.

Learn more

This post is for subscribers only

Sign up to read the post and as well as all other member only posts. Subscribing only takes a few seconds and will give you immediate access.
Subscribe now